EUIPO trademark

BYSTEAPIX

RegisteredEUIPOWord markClass 5

"BYSTEAPIX" is a word mark owned by Amgen Inc., filed at the EUIPO on June 12, 2026. It is registered and covers class 5 (Pharmaceuticals).

View Amgen Inc. portfolioGet this data via the API
Official EUIPO record
BYSTEAPIX
Word mark as filed with the EUIPO
Status
Registered
Since July 16, 2026
Filed
June 12, 2026
Registered
October 24, 2026
Expires
June 12, 2036
Application no.
019380028
Registration no.
019380028
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns BYSTEAPIX

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Amgen Inc.

AMGN

2,426 trademarks in the portfolioView company

Representative

Chiever BV

Chiever BV

Goods and services

What the mark covers

The products and services BYSTEAPIX is filed for, grouped by Nice class.

  • Pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, prostate, pancreatic, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders, including castration resistant prostate cancer; Pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders; Pharmaceutical preparations for use in the treatment of metastatic diseases; Pharmaceutical preparations for treating metabolic diseases and disorders; Pharmaceutical preparations for treating inflammatory and autoimmune diseases and diseases; Pharmaceutical preparations for treating or preventing cardiovascular and cerebrovascular diseases and disorders; Pharmaceutical preparations

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2026/132 Section A.1
FAQ

About BYSTEAPIX

Who owns the trademark "BYSTEAPIX"?

The EUIPO trademark "BYSTEAPIX" (application 019380028) is owned by Amgen Inc.

What is the status of "BYSTEAPIX"?

Its status at the EUIPO is: registered.

When was "BYSTEAPIX" registered?

It was registered on October 24, 2026 and is due to expire on June 12, 2036.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull BYSTEAPIX and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019eca18-8620-722b-b2a2-f362f608a0f8
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019eca18-8620-722b-b2a2-f362f608a0f8",
  "object": "trademark",
  "mark_text": "BYSTEAPIX",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "019380028",
  "filing_date": "2026-06-12",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Amgen Inc.",
      "entity_id": "ent_019eb6fb-7ab7-71bf-a46d-b0ba9848c4af"
    }
  ]
}